IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:IVG - NL0015000LU4 - Common Stock
18.885 EUR
+0.01 (+0.03%)
Overall IVG gets a fundamental rating of 4 out of 10. We evaluated IVG against 114 industry peers in the Machinery industry. IVG has a medium profitability rating, but doesn't score so well on its financial health evaluation. IVG is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
- IVG had positive earnings in the past year.
- In the past year IVG had a positive cash flow from operations.
- IVG had positive earnings in 4 of the past 5 years.
- In the past 5 years IVG always reported a positive cash flow from operatings.
1.2 Ratios
- IVG's Return On Assets of 1.73% is on the low side compared to the rest of the industry. IVG is outperformed by 62.28% of its industry peers.
- Looking at the Return On Equity, with a value of 12.39%, IVG is in the better half of the industry, outperforming 71.05% of the companies in the same industry.
- With a Return On Invested Capital value of 4.53%, IVG is not doing good in the industry: 60.53% of the companies in the same industry are doing better.
- Measured over the past 3 years, the Average Return On Invested Capital for IVG is significantly below the industry average of 9.14%.
- The 3 year average ROIC (3.91%) for IVG is below the current ROIC(4.53%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROIC | 4.53% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
1.3 Margins
- IVG's Profit Margin of 2.17% is on the low side compared to the rest of the industry. IVG is outperformed by 64.04% of its industry peers.
- In the last couple of years the Profit Margin of IVG has grown nicely.
- Looking at the Operating Margin, with a value of 5.00%, IVG is doing worse than 63.16% of the companies in the same industry.
- IVG's Operating Margin has improved in the last couple of years.
- IVG's Gross Margin of 16.49% is on the low side compared to the rest of the industry. IVG is outperformed by 92.11% of its industry peers.
- IVG's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% |
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
2. Health
2.1 Basic Checks
- IVG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for IVG has been reduced compared to 1 year ago.
- Compared to 5 years ago, IVG has more shares outstanding
- The debt/assets ratio for IVG has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.77, we must say that IVG is in the distress zone and has some risk of bankruptcy.
- IVG has a Altman-Z score of 1.77. This is comparable to the rest of the industry: IVG outperforms 42.11% of its industry peers.
- IVG has a debt to FCF ratio of 14.82. This is a negative value and a sign of low solvency as IVG would need 14.82 years to pay back of all of its debts.
- IVG has a Debt to FCF ratio of 14.82. This is in the lower half of the industry: IVG underperforms 68.42% of its industry peers.
- IVG has a Debt/Equity ratio of 1.35. This is a high value indicating a heavy dependency on external financing.
- IVG's Debt to Equity ratio of 1.35 is on the low side compared to the rest of the industry. IVG is outperformed by 84.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Altman-Z | 1.77 |
ROIC/WACC0.62
WACC7.34%
2.3 Liquidity
- A Current Ratio of 1.98 indicates that IVG should not have too much problems paying its short term obligations.
- With a decent Current ratio value of 1.98, IVG is doing good in the industry, outperforming 74.56% of the companies in the same industry.
- IVG has a Quick Ratio of 1.40. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
- IVG has a Quick ratio of 1.40. This is in the better half of the industry: IVG outperforms 77.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 |
3. Growth
3.1 Past
- IVG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.43%.
- Measured over the past years, IVG shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.82% on average per year.
- IVG shows a decrease in Revenue. In the last year, the revenue decreased by -7.24%.
- The Revenue has been growing slightly by 5.06% on average over the past years.
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%
3.2 Future
- The Earnings Per Share is expected to grow by 10.81% on average over the next years. This is quite good.
- The Revenue is expected to grow by 4.30% on average over the next years.
EPS Next Y-22.36%
EPS Next 2Y1.82%
EPS Next 3Y8.15%
EPS Next 5Y10.81%
Revenue Next Year-5.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.67%
Revenue Next 5Y4.3%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 14.09, which indicates a correct valuation of IVG.
- Based on the Price/Earnings ratio, IVG is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
- When comparing the Price/Earnings ratio of IVG to the average of the S&P500 Index (27.47), we can say IVG is valued slightly cheaper.
- The Price/Forward Earnings ratio is 8.76, which indicates a very decent valuation of IVG.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of IVG indicates a rather cheap valuation: IVG is cheaper than 87.72% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.26, IVG is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.09 | ||
| Fwd PE | 8.76 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, IVG is valued cheaply inside the industry as 80.70% of the companies are valued more expensively.
- 68.42% of the companies in the same industry are more expensive than IVG, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.8 | ||
| EV/EBITDA | 5.59 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.43
EPS Next 2Y1.82%
EPS Next 3Y8.15%
5. Dividend
5.1 Amount
- IVG has a Yearly Dividend Yield of 1.75%. Purely for dividend investing, there may be better candidates out there.
- IVG's Dividend Yield is a higher than the industry average which is at 1.55.
- Compared to an average S&P500 Dividend Yield of 1.89, IVG has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.75% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 27.33% of the earnings are spent on dividend by IVG. This is a low number and sustainable payout ratio.
DP27.33%
EPS Next 2Y1.82%
EPS Next 3Y8.15%
BIT:IVG (1/16/2026, 7:00:00 PM)
18.885
+0.01 (+0.03%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-06 2026-02-06/amc
Inst Owners33.94%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap5.12B
Revenue(TTM)14.48B
Net Income(TTM)322.00M
Analysts70.77
Price Target20.11 (6.49%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.75% |
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP27.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-15.44%
Max EPS beat(2)5.84%
EPS beat(4)3
Avg EPS beat(4)15.3%
Min EPS beat(4)-15.44%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)15.63%
EPS beat(12)8
Avg EPS beat(12)16.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-10.1%
Max Revenue beat(2)8.56%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-10.1%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.74%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-3.62%
EPS NY rev (3m)-13.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.49%
Revenue NY rev (3m)-3.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.09 | ||
| Fwd PE | 8.76 | ||
| P/S | 0.35 | ||
| P/FCF | 12.8 | ||
| P/OCF | 3.97 | ||
| P/B | 1.97 | ||
| P/tB | 9.28 | ||
| EV/EBITDA | 5.59 |
EPS(TTM)1.34
EY7.1%
EPS(NY)2.16
Fwd EY11.42%
FCF(TTM)1.47
FCFY7.81%
OCF(TTM)4.75
OCFY25.17%
SpS54.61
BVpS9.58
TBVpS2.04
PEG (NY)N/A
PEG (5Y)0.43
Graham Number17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROCE | 6% | ||
| ROIC | 4.53% | ||
| ROICexc | 5.79% | ||
| ROICexgc | 7.34% | ||
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% | ||
| FCFM | 2.7% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexgc growth 3Y26.65%
ROICexgc growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Debt/EBITDA | 2.37 | ||
| Cap/Depr | 119.97% | ||
| Cap/Sales | 6% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 86.98% | ||
| Profit Quality | 124.22% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | 1.77 |
F-Score6
WACC7.34%
ROIC/WACC0.62
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
EPS Next Y-22.36%
EPS Next 2Y1.82%
EPS Next 3Y8.15%
EPS Next 5Y10.81%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%
Revenue Next Year-5.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.67%
Revenue Next 5Y4.3%
EBIT growth 1Y-21.25%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year64.49%
EBIT Next 3Y27.62%
EBIT Next 5YN/A
FCF growth 1Y-7.83%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y-0.31%
OCF growth 3Y26.42%
OCF growth 5Y8.96%
IVECO GROUP NV / IVG.MI FAQ
Can you provide the ChartMill fundamental rating for IVECO GROUP NV?
ChartMill assigns a fundamental rating of 4 / 10 to IVG.MI.
What is the valuation status for IVG stock?
ChartMill assigns a valuation rating of 6 / 10 to IVECO GROUP NV (IVG.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for IVECO GROUP NV?
IVECO GROUP NV (IVG.MI) has a profitability rating of 4 / 10.
How financially healthy is IVECO GROUP NV?
The financial health rating of IVECO GROUP NV (IVG.MI) is 3 / 10.
Can you provide the expected EPS growth for IVG stock?
The Earnings per Share (EPS) of IVECO GROUP NV (IVG.MI) is expected to decline by -22.36% in the next year.